Improving cancer immunotherapy via co-delivering checkpoint blockade and thrombospondin-1 downregulator

The use of checkpoint-blockade antibodies is still restricted in several malignancies due to the modest efficacy, despite considerable success in anti-tumor immunotherapy. The poor response of cancer cells to immune destruction is an essential contributor to the failure of checkpoint therapy. We hyp...

Full description

Saved in:
Bibliographic Details
Main Authors: Qingqing Xiao (Author), Xiaotong Li (Author), Chang Liu (Author), Yuxin Jiang (Author), Yonglong He (Author), Wanting Zhang (Author), Helena S. Azevedo (Author), Wei Wu (Author), Yuanzheng Xia (Author), Wei He (Author)
Format: Book
Published: Elsevier, 2023-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available